Literature DB >> 27523738

Onychomycosis in patients with nail psoriasis: a point to point discussion.

Dimitrios Rigopoulos1, Vasilios Papanagiotou1, Ralph Daniel2, Bianca Maria Piraccini3.   

Abstract

Onychomycosis is the most common nail disease and affects large parts of the population. Psoriasis is a frequently encountered skin disorder with nail involvement being found in up to 80% of the patients at some time of the course of the disease. It has been postulated that onychomycosis occurs more frequently in patients with nail psoriasis, but the results of studies in the literature are controversial. Moreover, onychomycosis could exacerbate psoriasis through Koebner phenomenon and the treatment of psoriasis could predispose to onychomycosis. Finally, the differential diagnosis could be a real challenge due to many same clinical signs, the high prevalence and the possible coexistence of the two diseases. This article attempts to enlighten all these different aspects of a very close relationship.
© 2016 Blackwell Verlag GmbH.

Entities:  

Keywords:  coexistence; differential diagnosis; nails; onychomycosis; psoriasis

Mesh:

Year:  2016        PMID: 27523738     DOI: 10.1111/myc.12542

Source DB:  PubMed          Journal:  Mycoses        ISSN: 0933-7407            Impact factor:   4.377


  10 in total

Review 1.  [Differential diagnostic spectrum of psoriasis vs. psoriatic arthritis in skin and joints].

Authors:  S Gerdes; U Mrowietz; U Wagner
Journal:  Z Rheumatol       Date:  2017-08       Impact factor: 1.372

Review 2.  Variability in Systemic Treatment Efficacy for Onychomycosis: Information That Clinical Studies Do Not Impart to the Office Dermatologist.

Authors:  Avner Shemer; Ralph Daniel; Dimitris Rigopoulos; Renata Farhi; Meir Babaev
Journal:  Skin Appendage Disord       Date:  2017-10-26

Review 3.  Challenge of Nail Psoriasis: An Update Review.

Authors:  Chao Ji; Haiqing Wang; Chengbei Bao; Liangliang Zhang; Shifan Ruan; Jing Zhang; Ting Gong; Bo Cheng
Journal:  Clin Rev Allergy Immunol       Date:  2021-09-03       Impact factor: 8.667

Review 4.  New insight into the pathogenesis of nail psoriasis and overview of treatment strategies.

Authors:  Alessandra Ventura; Mauro Mazzeo; Roberta Gaziano; Marco Galluzzo; Luca Bianchi; Elena Campione
Journal:  Drug Des Devel Ther       Date:  2017-08-30       Impact factor: 4.162

Review 5.  Fungal Infections and Nail Psoriasis: An Update.

Authors:  Aikaterini Kyriakou; Sofia-Chrysovalantou Zagalioti; Myrto-Georgia Trakatelli; Christina Fotiadou; Zoe Apalla; Elizabeth Lazaridou; Aikaterini Patsatsi
Journal:  J Fungi (Basel)       Date:  2022-02-03

6.  Overall Prevalence and Prevalence Compared among Psoriasis Treatments of Onychomycosis in Patients with Nail Psoriasis and Fungal Involvement.

Authors:  Leena Chularojanamontri; Penvadee Pattanaprichakul; Charussri Leeyaphan; Panittra Suphatsathienkul; Supisara Wongdama; Sumanas Bunyaratavej
Journal:  Biomed Res Int       Date:  2021-12-13       Impact factor: 3.411

7.  Topical and device-based treatments for fungal infections of the toenails.

Authors:  Kelly Foley; Aditya K Gupta; Sarah Versteeg; Rachel Mays; Elmer Villanueva; Denny John
Journal:  Cochrane Database Syst Rev       Date:  2020-01-16

8.  The prevalence and etiological factors of onychomycosis in psoriatic patients.

Authors:  Alicja Romaszkiewicz; Barbara Bykowska; Monika Zabłotna; Michał Sobjanek; Martyna Sławińska; Roman J Nowicki
Journal:  Postepy Dermatol Alergol       Date:  2018-04-24       Impact factor: 1.837

9.  Onychomycosis in Psoriatic Patients with Nail Disorders: Aetiological Agents and Immunosuppressive Therapy.

Authors:  Núbia Carvalho Pena de Oliveira Praeiro Alves; Tomaz de Aquino Moreira; Lucivânia Duarte Silva Malvino; José Joaquim Rodrigues; Roberto Ranza; Lúcio Borges de Araújo; Reginaldo Dos Santos Pedroso
Journal:  Dermatol Res Pract       Date:  2020-05-02

10.  Combined laser and ozone therapy for onychomycosis in an in vitro and ex vivo model.

Authors:  Javier Fernández; Iván Del Valle Fernández; Claudio J Villar; Felipe Lombó
Journal:  PLoS One       Date:  2021-06-30       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.